In today’s post:
❌ Don't Buy This Stock. Yet.
❌ Don't Buy This Stock. Yet.
Viking Therapeutics $VKTX ( ▼ 5.54% ) just ripped back to 52-week highs above $40.
Analysts have a price target of $92.58 on it. That's 138.24% upside from here.
So the trade is obvious, right? Smash the buy button, wait for the money truck?
Not so fast. Because the chart is flashing a double top at $40, and the story underneath is more interesting than the headline. Let's figure out whether VKTX is actually a buy right now, or a great stock at the wrong price.
Subscribe to Daily Bull Run Premium+ to read the rest.
Every day we hand you at least one stock that should outperform — backed by research, charts, and a clear “why now.” No hype. No guessing. Just real analysis built to make you money.
UpgradeA subscription gets you:
- 📈 High-conviction stock picks every day — researched, explained, and timed for maximum impact
- 🧠 Deep-dive analysis — no fluff, just the “why it’s a winner” broken down clearly
- ⏳ Save hours of research — we do the digging, you get the insights
- 🧭 Clear buy thesis & risks — no vague calls, just full transparency
- 🔒 Early access to picks — before we even hint at them publicly
- 🏆 Designed to help you outperform — not just “inform” you
- 🔥 Zero hype. No jargon. Just real signals.